Current Ratio in % of Lexeo Therapeutics, Inc. from Q2 2024 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Lexeo Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2024 to Q3 2025.
  • Lexeo Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2025 was 487 %, a 37.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Lexeo Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 487 -292 -37.5% Sep 30, 2025
Q2 2025 474 -193 -28.9% Jun 30, 2025
Q1 2025 572 Mar 31, 2025
Q4 2024 733 Dec 31, 2024
Q3 2024 779 Sep 30, 2024
Q2 2024 667 Jun 30, 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.